Large-scale testing (Phase 3)Looking for participantsNCT07163611
What this trial is testing
Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
Who this might be right for
Membranous Nephropathy - PLA2R Induced
Radboud University Medical Center 20